Insider Trading & Ownership of Cormorant Asset Management, LP

Notable person
Bihua Chen
Location
Boston, MA
Summary
The estimated value of insider holdings of Cormorant Asset Management, LP is at least $1.08B dollars as of 15 Dec 2025. Cormorant Asset Management, LP is the 10%+ Owner of Ambrx Biopharma Inc. and owns shares of Ambrx Biopharma Cayman, Inc. stock worth about $642M. Cormorant Asset Management, LP is the Former 10% Owner of EyePoint Pharmaceuticals, Inc. and owns shares of EyePoint Pharmaceuticals, Inc. (EYPT) stock worth about $130M. Cormorant Asset Management, LP is the 10%+ Owner of Ambrx Biopharma, Inc. and owns shares of Ambrx Biopharma, Inc. stock worth about $110M. Cormorant Asset Management, LP is the Former 10% Owner of Monte Rosa Therapeutics, Inc. and owns shares of Monte Rosa Therapeutics, Inc. (GLUE) stock worth about $60.8M. Cormorant Asset Management, LP is the Former 10% Owner of Aerovate Therapeutics, Inc. and owns shares of Jade Biosciences, Inc. (JBIO) stock worth about $39.6M. Cormorant Asset Management, LP is the Former 10% Owner of BioAge Labs, Inc. and owns shares of BioAge Labs, Inc. (BIOA) stock worth about $29.3M. Cormorant Asset Management, LP is the 10%+ Owner of Corbus Pharmaceuticals Holdings, Inc. and owns shares of Corbus Pharmaceuticals Holdings, Inc. (CRBP) stock worth about $26.9M. Cormorant Asset Management, LP is the Former 10% Owner of Verve Therapeutics, Inc. and owns shares of Verve Therapeutics, Inc. (VERV) stock worth about $9.84M. Cormorant Asset Management, LP is the 10%+ Owner of Immuneering Corp and owns shares of Immuneering Corp (IMRX) stock worth about $8.6M. Cormorant Asset Management, LP is the Former 10% Owner of Tyra Biosciences, Inc. and owns shares of Tyra Biosciences, Inc. (TYRA) stock worth about $7.04M. Cormorant Asset Management, LP is the Former 10% Owner of Icosavax, Inc. and owns shares of Icosavax, Inc. stock worth about $6.68M. Cormorant Asset Management, LP is the Former 10% Owner of Ventyx Biosciences, Inc. and owns shares of Ventyx Biosciences, Inc. (VTYX) stock worth about $2.99M. Cormorant Asset Management, LP is the Former 10% Owner of Vigil Neuroscience, Inc. and owns shares of Vigil Neuroscience, Inc. (VIGL) stock worth about $2.31M. Cormorant Asset Management, LP is the Former 10% Owner of Pyxis Oncology, Inc. and owns shares of Pyxis Oncology, Inc. (PYXS) stock worth about $1.57M. Cormorant Asset Management, LP is the Former 10% Owner of Elevation Oncology, Inc. and owns shares of Elevation Oncology, Inc. (ELEV) stock worth about $1.14M.
Signature
CORMORANT ASSET MANAGEMENT, LP By: Cormorant Asset Management GP, LLC, Its General Partner By: /s/ Bihua Chen, Managing Member
All Insider Reports
All Insider Reports

Notify me when Cormorant Asset Management, LP files a new Insider Trading report.

⭐ Subscribe ⭐

Ownership of Cormorant Asset Management, LP

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
AMAM Ambrx Biopharma Cayman, Inc. 10%+ Owner $642M 15 Sep 2023
EYPT EyePoint Pharmaceuticals, Inc. Former 10% Owner $130M -$942K -0.72% 04 Dec 2025
AMAM Ambrx Biopharma, Inc. 10%+ Owner $110M 23 Oct 2023
GLUE Monte Rosa Therapeutics, Inc. Former 10% Owner $60.8M 28 Jun 2021
JBIO Jade Biosciences, Inc. Former 10% Owner $39.6M 02 Jul 2021
BIOA BioAge Labs, Inc. Former 10% Owner $29.3M 27 Sep 2024
CRBP Corbus Pharmaceuticals Holdings, Inc. 10%+ Owner $26.9M -$344K -1.26% 11 Dec 2025
VERV Verve Therapeutics, Inc. Former 10% Owner $9.84M 21 Jun 2021
IMRX Immuneering Corp 10%+ Owner $8.6M 01 Apr 2024
TYRA Tyra Biosciences, Inc. Former 10% Owner $7.04M 17 Sep 2021
ICVX Icosavax, Inc. Former 10% Owner $6.68M 02 Aug 2021
VTYX Ventyx Biosciences, Inc. Former 10% Owner $2.99M 25 Oct 2021
VIGL Vigil Neuroscience, Inc. Former 10% Owner $2.31M 11 Jan 2022
PYXS Pyxis Oncology, Inc. Former 10% Owner $1.57M 13 Oct 2021
ELEV Elevation Oncology, Inc. Former 10% Owner $1.14M 29 Jun 2021
OKUR OnKure Therapeutics, Inc. Former 10% Owner $0 -$3.41M -100% 15 May 2025
AARD Aardvark Therapeutics, Inc. Former 10% Owner 14 Feb 2025
DRUG BRIGHT MINDS BIOSCIENCES INC. 10%+ Owner 04 Nov 2024
GRNA GreenLight Biosciences Holdings, PBC Other* 20 Jul 2023

Insider Transactions Reported by Cormorant Asset Management, LP:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.